Use of SGLT2i versus DPP-4i as an add-on therapy and the risk of PAD-related surgical events (amputation, stent placement, or vascular surgery): a cohort study in veterans with diabetes
Griffin KE, Snyder K, Snyder K, et al.
Diabetes Care. 2024:dc241546.
Leggi